Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olaf Hoffmann

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Acta Neuropathologica Communications|April 29, 2016
Differential roles of hypoxia and innate immunity in juvenile and adult dermatomyositisCorinna Preuße, Yves Allenbach, Olaf Hoffmann, et al.
Journal of Medical Internet Research|October 6, 2021
Multiple Sclerosis Progression Discussion Tool Usability and Usefulness in Clinical Practice: Cross-sectional, Web-Based SurveyTjalf Ziemssen, Gavin Giovannoni, Enrique Alvarez, et al.
BMC Neurology|January 20, 2017
Electrocardiographic assessments and cardiac events after fingolimod first dose - a comprehensive monitoring studyVolker Limmroth, Tjalf Ziemssen, Michael Lang, et al.
Der Nervenarzt|July 23, 2021
[Multiple sclerosis treatment consensus group (MSTCG): position paper on disease-modifying treatment of multiple sclerosis 2021 (white paper)]Heinz Wiendl, Ralf Gold, Thomas Berger, et al.
Therapeutic Advances in Neurological Disorders|August 23, 2021
Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)Heinz Wiendl, Ralf Gold, Thomas Berger, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Acta Neuropathologica Communications|April 29, 2016
Differential roles of hypoxia and innate immunity in juvenile and adult dermatomyositisCorinna Preuße, Yves Allenbach, Olaf Hoffmann, et al.
Journal of Medical Internet Research|October 6, 2021
Multiple Sclerosis Progression Discussion Tool Usability and Usefulness in Clinical Practice: Cross-sectional, Web-Based SurveyTjalf Ziemssen, Gavin Giovannoni, Enrique Alvarez, et al.
BMC Neurology|January 20, 2017
Electrocardiographic assessments and cardiac events after fingolimod first dose - a comprehensive monitoring studyVolker Limmroth, Tjalf Ziemssen, Michael Lang, et al.
Der Nervenarzt|July 23, 2021
[Multiple sclerosis treatment consensus group (MSTCG): position paper on disease-modifying treatment of multiple sclerosis 2021 (white paper)]Heinz Wiendl, Ralf Gold, Thomas Berger, et al.
Therapeutic Advances in Neurological Disorders|August 23, 2021
Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)Heinz Wiendl, Ralf Gold, Thomas Berger, et al.
Pageof 5